Transforming the chemicals industry, AI application models enhance formulation development, enabling rapid, accurate responses to evolving market demands.

Life runs on instructions you never see. Every cell reads DNA, turns that message into RNA, and then builds proteins that ...

A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has missed its primary endpoint. | A phase 2a trial of NMD ...

Neither stenting nor endarterectomy provided a boost versus medical therapy alone in patients with asymptomatic stenosis.

This is the January 2026 edition of Anchovy News. Here you will find articles concerning ICANN, the domain name industry and ...

Alphabet Inc. operates a diversified technology platform Search and advertising anchor core operations Global digital services span multiple industries Alphabet Inc. (NASDAQ:GOOG) remains a central ...

PSCI shared perspective on how artificial intelligence is influencing information technology roles across project-based and ...

Five days isolated in complete darkness retunes the senses. Scientist Kiana Aran explains how sensors help to share the ...

Thomson Reuters Corporation ( TRI:CA) Q4 2025 Earnings Call February 5, 2026 8:30 AM EST Good day, everyone, and welcome to ...

The Luxury Chalet Company released an industry announcement addressing the expanding presence of artificial intelligence ...

LANZHOU, Feb. 6 (Xinhua) -- Chinese scientists have newly presented key evidence demonstrating that spatial pattern formation drives the ecological resilience of alpine marsh on the Qinghai-Tibet ...

NMD Pharma is accelerating ignaseclant’s clinical development in CMT alongside multiple near-term clinical catalysts across its neuromuscular pipeline, with Phase 2 studies in spinal muscular atrophy ...